skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

About David

San Diego, USA

+22 year(s) experience

David Dahan Pharmaintelligence
As a Scientific Analyst for Biomedtracker, David Dahan provides analytical comments on the major events of the day and answers queries from our customers in the pharma and investment community.
David covers a wide range of indications, including infectious diseases, cancer (hematologic, breast and ovarian) and obstetrics/gynecology. He looks at everything from the release of data from clinical trials to NIH Advisory Committee meetings. He also prepares post-meeting reports and interviews key opinion leaders.

In 2016 David covered the ASCO meeting, the world’s largest cancer research meeting.

Before joining us, David worked for 10 years as a Senior Scientist discovering novel small molecule flavour enhancers. He holds a BSc and PhD in Microbiology and Immunology from McGill University.

Analyst Articles